Anti-platelet agents in pediatric cardiac practice
Open Access
- 1 January 2013
- journal article
- review article
- Published by Medknow in Annals of Pediatric Cardiology
- Vol. 6 (1), 59-64
- https://doi.org/10.4103/0974-2069.107236
Abstract
Pediatric patients with a variety of congenital and acquired cardiac conditions receive antithrombotic therapy. Many of the indications are empirical, and have either not been proven in controlled studies or are extrapolated from adult studies. This article reviews the current available literature regarding the use of anti-platelet drugs in the pediatric cardiac population.Keywords
This publication has 34 references indexed in Scilit:
- Childhood Arterial Ischemic Stroke: A Review of Etiologies, Antithrombotic Treatments, Prognostic Factors, and Priorities for Future ResearchSeminars in Thrombosis and Hemostasis, 2011
- Management of myocardial infarction in children with Kawasaki diseaseBlood Coagulation & Fibrinolysis, 2010
- Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease?The American Journal of Cardiology, 2010
- Vasculitis in Children and AdolescentsPediatric Drugs, 2009
- Overview of Late Outcome of Medical and Surgical Treatment for Takayasu ArteritisCirculation, 2008
- Hybrid Intraoperative Pulmonary Artery Stent Placement for Congenital Heart DiseaseThe American Journal of Cardiology, 2008
- Safety and Efficacy of Clopidogrel in Children with Heart DiseaseThe Journal of Pediatrics, 2008
- Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actionsBlood, 2006
- Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl AlcoholThe Journal of pharmacology and experimental therapeutics, 2006
- Aspirin dosage for infants and childrenThe Journal of Pediatrics, 1979